Comparison of alprazolam, imipramine, and placebo in the treatment of depression.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  1983-06-10

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/JAMA.1983.03330460039029PMID 6133970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Benzodiazepines as antidepressants. A triazolobenzodiazepine used to treat depression.

  1982cited by this paper
• Adverse effects of antidepressant drugs. Part 1: monoamine oxidase inhibitors and tricyclics.

  1981cited by this paper
• Alprazolam compared to diazepam and placebo in the treatment of anxiety.

  1980cited by this paper
• Anxiolytic Efficacy of Alprazolam Compared to Diazepam and Placebo

  1980cited by this paper
• Alprazolam compared to diazepam and placebo in the treatment of anxiety.

  1980cited by this paper
• A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness

  1979cited by this paper
• New perspectives on the mode of action of antidepressant drugs

  1979cited by this paper
• Benzodiazepines in Depressive Disorders

  1978cited by this paper
• Pharmacology of some metabolites of triazolam, alprazolam, and diazepam prepared by a simple, one-step oxidation of benzodiazepines.

  1978cited by this paper
• Reliability of psychiatric diagnosis. I. A methodological review.

  1977cited by this paper
• Pilot open label study with alprazolam (U31, 889) in outpatients with neurotic depression.

  1976cited by this paper
• A user's guide to SAS 76

  1976cited by this paper
• Anxiolytic effects of a new triazolobenzodiazepine, U-31,889.

  1973cited by this paper
• Diagnostic criteria for use in psychiatric research.

  1972cited by this paper
• Development of a rating scale for primary depressive illness.

  1967cited by this paper
• Simultaneous Statistical Inference

  1967cited by this paper

• Examining the efficacy of antidepressant pharmacotherapy for interpersonal sensitivity in patients with depressive disorders

  2025cites this paper
• Catatonia and melancholia interface: exploring a new paradigm for evaluation and treatment. A case series and literature review

  2024cites this paper
• [Systematics and treatment of anxiety disorders].

  2020cites this paper
• Antidepressants Misrepresented

  2018cites this paper
• Benzodiazepines as a Monotherapy in Depressive Disorders: A Systematic Review

  2018cites this paper
• The Black Book of Psychotropic Dosing and Monitoring.

  2018cites this paper
• Spectroscopic investigation, molecular interactions and molecular docking studies on 8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

  2016cites this paper
• The Ability of BDNF to Modify Neurogenesis and Depressive-Like Behaviors Is Dependent upon Phosphorylation of Tyrosine Residues 365/367 in the GABAA-Receptor γ2 Subunit

  2013cites this paper
• Randomized, Placebo-Controlled Trials of Antidepressants for Acute Major Depression: Thirty-Year Meta-Analytic Review

  2012cites this paper
• Alprazolam for depression.

  2012cites this paper
• Psychiatric Aspects of Cutaneous Surgery

  2012cites this paper
• Exploratory Review of Placebo Characteristics Reported in Randomised Placebo Controlled Antidepressant Drug Trials

  2011cites this paper
• Simultaneous determination of alprazolam and fluoxetine hydrochloride in tablet formulations by high-performance column liquid chromatography and high-performance thin-layer chromatography.

  2009cites this paper
• Mechanisms of action of the mood stabilizer valproate: A focus on GSK-3 inhibition

  2008cites this paper
• Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials

  2007cites this paper
• Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.

  2006cites this paper
• Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects

  2005cites this paper
• Is there a delay in the antidepressant effect? A meta-analysis.

  2005cites this paper
• Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder

  2004cites this paper
• Clinical Pharmacology, Clinical Efficacy, and Behavioral Toxicity of Alprazolam: A Review of the Literature

  2004cites this paper
• Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: Interactions with Yohimbine

  2004cites this paper
• Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration

  2004cites this paper
• Quantificationof Alprazolamin Serumor Plasmaby LiquidChromatography

  2004cites this paper
• Meta-Analysis of Placebo Rates in Major Depressive Disorder Trials

  2003cites this paper
• Benzodiazepines and anterior pituitary function

  2002cites this paper
• The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues.

  2002cites this paper
• ALPRAZOLAM: profilo farmacoeconomico nei disturbi d’ansia e da attacchi di panico

  2002cites this paper
• Effect of prenatal alprazolam exposure on anxiety patterns in rat offspring.

  2002cites this paper
• Effect of prenatal alprazolam exposure on anxiety patterns in rat offspring.

  2002cites this paper
• Placebo response in studies of major depression: variable, substantial, and growing.

  2002cites this paper
• Anxiety disorders and major depression, together or apart

  2001cites this paper
• Open study of effects of alprazolam on seasonal affective disorder

  2001cites this paper
• Living with anxiety disorders: as good as it gets...?

  2000cites this paper
• Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression.

  2000cites this paper
• Concordance between self-report and clinician's assessment of depression.

  1999cites this paper
• Psychopharmacology in supportive care of cancer: a review for the clinician

  1999cites this paper
• Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans.

  1999cites this paper
• Alprazolam increases dehydroepiandrosterone concentrations.

  1999cites this paper
• Psychopharmacology in supportive care in cancer: a review for the clinician

  1999cites this paper
• In situ hybridization histochemistry as a method to assess GABAAreceptor subunit mRNA expression following chronic alprazolam administration

  1999cites this paper
• Depression and demoralization among Russian-Jewish immigrants in primary care.

  1999cites this paper
• Common psychosocial factors in psychiatric drug therapy.

  1999cites this paper
• The Influence of Alprazolam on the Monoaminergic Neurotransmitter Systems in Dysthymic Patients. Relationship to Clinical Response

  1998cites this paper
• Toward a generalizable model of symptoms in major depressive disorder.

  1998cites this paper
• Comparación del comienzo del efecto de los antidepresivos: consideraciones pragmáticas sobre los métodos y los puntos finales

  1998cites this paper
• Pharmacologic Treatments Effective in Both Generalized Anxiety Disorder and Major Depressive Disorder: Clinical and Theoretical Implications

  1998cites this paper
• Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study.

  1998cites this paper
• Comparing onset of effect of antidepressants: Pragmatic considerations on methods and end-points

  1998cites this paper
• Panic disorder: long-term pharmacotherapy and discontinuation.

  1998cites this paper
• Alprazolam as an Alternative to Low‐Dose Haloperidol in Older, Cognitively Impaired Nursing Facility Patients

  1998cites this paper
• Stress, the hypothalamic-pituitary-adrenal axis, and vulnerability to drug abuse.

  1998cites this paper
• Factors that influence the outcome of placebo-controlled antidepressant clinical trials.

  1997cites this paper
• Adverse cutaneous reactions to psychotropic drugs.

  1997cites this paper
• A neuroendocrine role in cocaine reinforcement.

  1997cites this paper
• The long-term management of generalized anxiety disorder: issues and dilemmas.

  1996cites this paper
• Antidepressant Treatment of Depression: A Metaanalysis

  1996cites this paper
• Circadian rhythms and the pharmacology of affective illness.

  1996cites this paper
• Benzodiazepines for depression? A review of the literature.

  1995cites this paper
• Multiple approaches in neuronal activity for treating depression: More effective, more types of receptors?

  1995cites this paper
• Maintenance treatment studies in anxiety disorders: some methodological notes.

  1995cites this paper
• Benzodiazepines as antidepressants: does GABA play a role in depression?

  1995cites this paper
• Self-rating procedures in the evaluation of antidepressants.

  1995cites this paper
• Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo

  1995cites this paper
• Alprazolam and amitriptyline in the treatment of moderate depression

  1994cites this paper
• Acute effects of benzodiazepines on operant behavior and in vivo receptor binding in mice.

  1994cites this paper
• Do benzodiazepines have a role in chronic pain management?

  1994cites this paper
• Management of depression. Current options for this highly treatable disorder.

  1994cites this paper
• Management of depression.

  1994cites this paper
• Alprazolam in the Treatment of Two Subsamples of Patients With Late Luteal Phase Dysphoric Disorder: A Double‐Blind, Placebo‐Controlled Crossover Study

  1994cites this paper
• Does a Placebo Run-In or a Placebo Treatment Cell Affect the Efficacy of Antidepressant Medications?

  1994cites this paper
• [Exacerbation of an affective psychosis after terminating a decade of benzodiazepine treatment. Which therapeutic procedure is sensible?].

  1994cites this paper
• Trizyklische Antidepressiva in der Allgemeinarztpraxis

  1994cites this paper
• Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo.

  1994cites this paper
• Adjuvant alprazolam treatment of mixed anxiety-depressive disorder in chronic schizophrenic patients

  1994cites this paper
• Alprazolam and depression: a review of risks and benefits.

  1993cites this paper
• A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.

  1993cites this paper
• Long-term efficacy of tianeptine on alcoholic relapses in non-depressed alcoholic patients. Preliminary results

  1993cites this paper
• Discontinuation reactions to alprazolam in panic disorder.

  1993cites this paper
• Mixed anxiety and depression: clinical implications.

  1993cites this paper
• Efficacy and acceptability of tianeptine in the elderly: a review of clinical trials

  1993cites this paper
• The treatment of generalized anxiety disorder in patients with depressive symptomatology.

  1993cites this paper
• Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.

  1993cites this paper
• Clinical Uses of Benzodiazepines

  1993cites this paper
• Recognition and Management of Anxiety in the Intensive Care Unit

  1993cites this paper
• Mixed anxiety and depression: diagnostic issues.

  1993cites this paper
• Rapid relief of anxiety in cancer patients with both alprazolam and placebo.

  1993cites this paper
• BENZODIAZEPINES IN PSYCHOTIC STATES

  1993cites this paper
• How to manage anxious patients who are depressed.

  1993cites this paper
• Characterization of the Binding and Comparison of the Distribution of Benzodiazepine Receptors Labeled with [3H]Diazepam and [3H]Alprazolam

  1993cites this paper
• Tritiated and deuterated alprazolam. The use of deuterium NMR to study isotope exchange in tritiated alprazolam

  1993cites this paper
• A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.

  1992cites this paper
• Efficacy of treatments for posttraumatic stress disorder. An empirical review.

  1992cites this paper
• Benzodiazepines. Depressants or antidepressants?

  1992cites this paper
• Gepirone, a selective serotonin (5HT1A) partial agonist in the treatment of major depression.

  1992cites this paper
• Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies

  1992cites this paper
• Comparison of clomipramine, alprazolam and placebo in the treatment of obsessive—compulsive disorder

  1992cites this paper
• The cancer patient with pain: psychiatric complications and their management.

  1992cites this paper
• Effects of Chronic Ethanol and Benzodiazepine Treatment and Withdrawal on Corticotropin‐releasing Factor Neural Systems a

  1992cites this paper
• Long-Term Administration of Tianeptine in Depressed Patients after Alcohol Withdrawal

  1992cites this paper
• Potential Involvement of Anxiety in the Neurobiology of Cocaine a

  1992cites this paper